黄色大片在线,天天综合网天天综合,成年人免费毛片

熱門搜索化學品最多只顯示前20條，請點擊“搜索化學品”查看所有結果

CAS登錄號

中文名

英文名

分子結構式

分子式

詳情

供應商

111812-58-9

唑螨酯;
(E)-4-[[[[(1,3-二甲基-5-苯氧基-吡唑-4-基)亞甲基]氨基]氧]甲基]苯甲酸特丁酯

Fenpyroximate;
4-[[[[(1,3-Dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino]oxy]methyl]-benzoic acid 1,1-dimethylethyl ester

唑螨酯;
(E)-alpha-(1,3-二甲基-5-苯氧基吡唑-4-亞甲基氨基氧)對甲苯甲酸叔丁酯

Fenpyroximate;
1,1-Dimethylethyl (E)-4-(((((1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene)amino)oxy)methyl)benzoate;
tert-Butyl (E)-4-(((((1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene)amino)oxy)methyl)benzoat

Benzoic acid,4-[[(2,5-dihydroxyphenyl)methyl]amino]-, tricyclo[3.3.1.13,7]dec-1-yl ester;
Adaphostin;
NSC 680410

Benzoic acid,4,4'-[(phenylphosphinothioylidene)diimino]bis-, diethyl ester (9CI);
Benzoicacid, 4,4'-[(phenylphosphinothioylidene)diimino]di-, diethyl ester (6CI,8CI);
NSC 36882

N-芴甲氧羰基-3-環(huán)己基-D-丙氨酸

Cyclohexanepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(aR)-;
Cyclohexanepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(R)-

N-芴甲氧羰基-3-環(huán)己基-L-丙氨酸

Cyclohexanepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(aS)-;
Cyclohexanepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(S)-;
(S)-2-[[[(9H-Fluoren-9-yl)methoxy]carbonyl]amino]-3-cyclohexylpropanoicacid;
(S)-3-Cyclohexyl-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]propionicacid;
(S)-N-Fmoc-cyclohexylalanine

(S)-N-FMOC-氨基-2-環(huán)己基-丙酸

Cyclohexaneacetic acid,a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-a-methyl-, (aS)-

Cyclohexaneacetic acid,1-[[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]methyl]-;
(1-[(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-METHYL]-CYCLOHEXYL)-ACETIC ACID;
FMOC-1-AMINOMETHYL-CYCLOHEXANE ACETIC ACID;
FMOC-GABAPENTIN;
FMOC-GPN

Carbamic acid,[3-amino-4-[(diphenylmethyl)amino]-2,6-pyridinediyl]bis-, diethyl ester (9CI);
2,6-Pyridinedicarbamicacid, 3-amino-4-[(diphenylmethyl)amino]-, diethyl ester (7CI);
NSC 91005

Cyclooctanecarboxylicacid, 1-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-;
FMOC-1-AMINO-1-CYCLOOCTANECARBOXYLIC ACID;
Cyclooctanecarboxylic acid, 1-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- (9CI);
Fmoc-1-amino-cyclooctane carboxylic acid

Cyclohexanepropanoicacid, a-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-

Cyclohexanecarboxylicacid, 4-[[[(9H-fluoren-9-ylmethoxy)carbonyl]methylamino]methyl]-, trans-;
TRANS4(FMOCMETHYLAMINOMETHYL)CYCLOHEXANECARBOXYLICACID

Dibenzo[f,h]pyrrolo[1,2-b]isoquinoline,9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (13aS)-;
Dibenzo[f,h]pyrrolo[1,2-b]isoquinoline,9,11,12,13,13a,14-hexahydro-2,3,6,7-tetramethoxy-, (S)-;
Tylophorine(6CI,7CI,8CI);
(+)-(S)-Tylophorine;
(+)-Tylophorine;
(S)-9,11,12,13,13a,14-Hexahydro-2,3,6,7-tetramethoxydibenzo[f,h]pyrrolo[1,2-b]isoquinoline;
NSC 717335;
NSC 76387;
NSTP 0G01;
Tylophorin;
Tylophorine, (+)-

Isoquinolinium,5-(acetyloxy)-2-ethyl-, bromide (1:1);
Isoquinolinium,2-ethyl-5-hydroxy-, bromide, acetate (8CI);
Isoquinolinium,5-(acetyloxy)-2-ethyl-, bromide (9CI)

Propanoic acid,2-hydroxy-, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinylester;
Haloperidollactate

1H-Pyrrole-3,4-dimethanol,2-[1,1'-biphenyl]-4-yl-1,5-dimethyl-, bis(methylcarbamate) (ester) (9CI);
NSC 301480

3(2H)-Pyridazinone,4,6-bis(4-methoxyphenyl)-2-[2-(4-morpholinyl)ethyl]-;
3(2H)-Pyridazinone,4,6-bis(p-methoxyphenyl)-2-(2-morpholinoethyl)- (8CI)

4',4''-BIS(DIMETHYLAMINO)-4-METHOXY-3-SULFOTRITYL INNER SALT;
e]-2,5-cyclohexadien-1-ylidene]-n-methyl-,hydroxide,innersalt;
methanaminium,n-[4-[[4-(dimethylamino)phenyl](4-methoxy-3-sulfophenyl)methylen;
N-[4-(((4-DIMETHYLAMINO)PHENYL)(4-METHOXY-3-SULFOPHENYL)METHYLENE)-2,5-CYCLOHEXADIEN-1-YLIDENE]-N-METHYLMETHANAMINIUM;
4',4''-Bis(dimethylamino)-4-methoxy-3-sulfotrityl;
4',4''-BIS(DIMETHYLAMINO)-4-METHOXY-3-SULFOTRITYL INNER SALT;
[4-[[4-(dimethylamino)phenyl](4-methoxy-3-sulphonatophenyl)methylene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium;
n-[4-(((4-dimethylamino)phenyl)(4-methoxy-3-sulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene]-n-methylmethanaminium;
4'',4''-BIS(DIMETHYLAMINO)-4-METHOXY-3-SULFOTRITYL INNER SALT 97%

[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯;
[4-[(羥基氨基)羰基]苯基]氨基甲酸

[4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl este

N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽水合物;
N-[4-[(羥基氨基)羰基]苯基]氨基甲酸 [6-[(二乙基氨基)甲基]-2-萘基]甲酯鹽酸鹽水合物

ITF2357;
ITF2357;
ITF2357 (Givinostat);
N-[4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester hydrochloride hydrate

無

C24H27N3O4.HCl.H2O

詳情

供應商

化工產品